Application of membrane-active peptides for nonviral gene delivery

被引:154
|
作者
Wagner, E [1 ]
机构
[1] Univ Vienna, Bioctr, Inst Biochem, A-1030 Vienna, Austria
关键词
polylysine; polyethylenimine; receptor-mediated gene transfer; endosomal release; amphipathic peptides; transfection;
D O I
10.1016/S0169-409X(99)00033-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A variety of membrane-modifying agents including pH-specific fusogenic or lytic peptides, bacterial proteins, lipids, glycerol, or inactivated virus particles have been evaluated for the enhancement of DNA-polycation complex-based gene transfer. The enhancement depends on the characteristics of both the cationic carrier for DNA and the membrane-modifying agent. Peptides derived from viral sequences such as the N-terminus of influenza virus haemagglutinin HA-2, the N-terminus of rhinovirus HRV2 VP-1 protein, and other synthetic or natural sequences such as the amphipathic peptides GALA, KALA, EGLA JTS1, or gramicidin S have been tested. Ligand-polylysine-mediated gene transfer can be improved up to more than 1000-fold by membrane-active compounds. Other polycations like dendrimers or polyethylenimines as well as several cationic lipids provide a high transfection efficiency per se. Systems based on these polymers or lipids are only slightly enhanced by endosomolytic peptides or adenoviruses. Electroneutral cationic lipid-DNA complexes however can be strongly improved by the addition of membrane-active peptides, (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:279 / 289
页数:11
相关论文
共 50 条
  • [1] Application of membrane-active peptides for drug and gene delivery across cellular membranes
    Plank, C
    Zauner, W
    Wagner, E
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 34 (01) : 21 - 35
  • [2] Application of membrane-active peptides for drug and gene delivery across cellular membranes
    Institute of Biochemistry, Vienna Univ. Biocenter, Dr. B., A-1030 Vienna, Austria
    Adv. Drug Deliv. Rev., 1 (21-35):
  • [3] Membrane-Active Peptides and Their Potential Biomedical Application
    Gostaviceanu, Andreea
    Gavrilas, Simona
    Copolovici, Lucian
    Copolovici, Dana Maria
    PHARMACEUTICS, 2023, 15 (08)
  • [4] Effects of membrane-active agents in gene delivery
    Wagner, E
    JOURNAL OF CONTROLLED RELEASE, 1998, 53 (1-3) : 155 - 158
  • [5] Application of Peptides in Construction of Nonviral Vectors for Gene Delivery
    Yang, Yujie
    Liu, Zhen
    Ma, Hongchao
    Cao, Meiwen
    NANOMATERIALS, 2022, 12 (22)
  • [6] A common landscape for membrane-active peptides
    Last, Nicholas B.
    Schlamadinger, Diana E.
    Miranker, Andrew D.
    PROTEIN SCIENCE, 2013, 22 (07) : 870 - 882
  • [7] Special issue on membrane-active peptides
    Sergiy Afonin
    Davor Juretić
    Frances Separovic
    Anne S. Ulrich
    European Biophysics Journal, 2011, 40 : 347 - 348
  • [8] Synergies with and Resistance to Membrane-Active Peptides
    Kmeck, Adam
    Tancer, Robert J.
    Ventura, Cristina R.
    Wiedman, Gregory R.
    ANTIBIOTICS-BASEL, 2020, 9 (09): : 1 - 15
  • [9] Simulation studies of membrane-active peptides
    La Rocca, P
    Shai, Y
    Sansom, MSP
    BIOPHYSICAL JOURNAL, 1998, 74 (02) : A304 - A304
  • [10] Membrane-Active Peptides: Mechanisms of Action
    Alves, Isabel D.
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2012, 13 (07) : 601 - 601